
Ipsen S.A (IPN) | Financial Analysis & Statements
Ipsen S.A. | Large-cap | Healthcare
Ipsen S.A. | Large-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
3.6B
Gross Profit
3.0B
82.69%
Operating Income
696.0M
19.47%
Net Income
347.3M
9.72%
EPS (Diluted)
€4.15
Balance Sheet Metrics
Total Assets
6.4B
Total Liabilities
2.3B
Shareholders Equity
4.2B
Debt to Equity
0.54
Cash Flow Metrics
Operating Cash Flow
325.3M
Free Cash Flow
133.0M
Revenue & Profitability Trend
Ipsen S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 3.6B | 3.3B | 3.2B | 2.7B | 2.7B |
Cost of Goods Sold | 618.7M | 571.2M | 527.7M | 438.6M | 490.6M |
Gross Profit | 3.0B | 2.7B | 2.6B | 2.3B | 2.2B |
Operating Expenses | 2.0B | 2.0B | 1.8B | 1.5B | 1.5B |
Operating Income | 696.0M | 570.4M | 871.3M | 853.5M | 724.2M |
Pre-tax Income | 431.6M | 761.5M | 706.1M | 789.2M | 532.4M |
Income Tax | 74.9M | 136.2M | 112.3M | 158.3M | -17.8M |
Net Income | 347.3M | 647.2M | 647.5M | 646.7M | 548.9M |
EPS (Diluted) | €4.15 | €7.73 | €7.81 | €7.76 | €6.57 |
Income Statement Trend
Ipsen S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 2.0B | 1.9B | 2.4B | 2.0B | 1.6B |
Non-Current Assets | 4.4B | 4.4B | 3.2B | 3.0B | 2.7B |
Total Assets | 6.4B | 6.3B | 5.6B | 5.0B | 4.3B |
Liabilities | |||||
Current Liabilities | 1.5B | 1.6B | 1.3B | 1.2B | 1.2B |
Non-Current Liabilities | 751.8M | 872.3M | 935.8M | 1.0B | 966.0M |
Total Liabilities | 2.3B | 2.5B | 2.3B | 2.3B | 2.2B |
Equity | |||||
Total Shareholders Equity | 4.2B | 3.8B | 3.3B | 2.7B | 2.1B |
Balance Sheet Composition
Ipsen S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 357.3M | 619.9M | 592.1M | 631.2M | 548.9M |
Operating Cash Flow | 325.3M | 723.3M | 636.2M | 581.2M | 587.3M |
Investing Activities | |||||
Capital Expenditures | -173.0M | -116.2M | -86.6M | -87.7M | -81.4M |
Investing Cash Flow | -240.4M | -1.0B | -302.3M | -2.8M | -119.4M |
Financing Activities | |||||
Dividends Paid | -99.6M | -99.6M | -99.3M | -82.9M | -83.2M |
Financing Cash Flow | -123.6M | -3.0B | -1.4B | -1.4B | -307.2M |
Free Cash Flow | 133.0M | 677.0M | 718.5M | 475.4M | 630.6M |
Cash Flow Trend
Ipsen S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.61
Forward P/E
9.95
Price to Book
1.99
Price to Sales
2.34
PEG Ratio
9.95
Profitability Ratios
Profit Margin
9.68%
Operating Margin
28.46%
Return on Equity
8.93%
Return on Assets
8.23%
Financial Health
Current Ratio
1.34
Debt to Equity
12.33
Beta
0.19
Per Share Data
EPS (TTM)
€4.27
Book Value per Share
€50.58
Revenue per Share
€43.19
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ipn | 8.4B | 23.61 | 1.99 | 8.93% | 9.68% | 12.33 |
Boiron S.A | 395.0M | 35.00 | 1.04 | 2.95% | 2.33% | 3.96 |
Euroapi S.A.S.U | 282.4M | 8.84 | 0.29 | -13.67% | -14.21% | 7.03 |
CoreTech Limited | 4.3M | - | - | -102.42% | 137.36% | -0.95 |
Rapid Nutrition Plc | 2.7M | - | 1.62 | -1,376.37% | 52.57% | 23.09 |
21Shares Cronos ETP | 0 | - | - | 0.00% | 0.00% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.